BACKGROUND: This study investigated the association between dimensional personality traits from the Five-Factor Model (FFM) and treatment outcome in patients with Major Depressive Disorder (MDD). METHODS:Six hundred forty-nine outpatients with MDD participated in a randomised double-blind longitudinal study for 6 months. Patients received a combination of medication and psychotherapy; they were randomised to medication condition (tianeptine or fluoxetine), and non-randomly assigned to psychotherapy condition (supportive, cognitive-behavioural, or psychodynamic). The Montgomery Asberg Depression Rating Scale was used to assess depression severity. The Système de Description en Cinq Dimensions was used to assess the personality domains of the FFM. RESULTS: Group comparisons revealed that patients who responded to both medication and psychotherapy had lower Neuroticism (t=4.22, p<.01), and higher Extraversion (t=4.01, p<.01) and Openness to Experience scores (t=3.57, p<.01) compared to non-responders. Regression analyses, which controlled for shared variance among the five personality domains, indicated that Neuroticism (chi(2)=4.06, p=.04) and Conscientiousness (chi(2)=8.98, p<.01) were significantly and uniquely associated with response. The two-way interactions between NeuroticismxExtraversion (chi(2)=4.49, p=.03) and ExtraversionxConscientiousness (chi(2)=5.91, p=.01) were also associated with response. These results were mostly replicated across the treatment-completer and intent-to-treat samples. CONCLUSIONS:Dimensional personality traits predict response for individuals with MDD. LIMITATIONS: This study did not examine facet-level traits, patient pre-morbid personality and functioning, and additional patient characteristics. Results may not be generalizable to severely depressed or treatment refractory patients.
RCT Entities:
BACKGROUND: This study investigated the association between dimensional personality traits from the Five-Factor Model (FFM) and treatment outcome in patients with Major Depressive Disorder (MDD). METHODS: Six hundred forty-nine outpatients with MDD participated in a randomised double-blind longitudinal study for 6 months. Patients received a combination of medication and psychotherapy; they were randomised to medication condition (tianeptine or fluoxetine), and non-randomly assigned to psychotherapy condition (supportive, cognitive-behavioural, or psychodynamic). The Montgomery Asberg Depression Rating Scale was used to assess depression severity. The Système de Description en Cinq Dimensions was used to assess the personality domains of the FFM. RESULTS: Group comparisons revealed that patients who responded to both medication and psychotherapy had lower Neuroticism (t=4.22, p<.01), and higher Extraversion (t=4.01, p<.01) and Openness to Experience scores (t=3.57, p<.01) compared to non-responders. Regression analyses, which controlled for shared variance among the five personality domains, indicated that Neuroticism (chi(2)=4.06, p=.04) and Conscientiousness (chi(2)=8.98, p<.01) were significantly and uniquely associated with response. The two-way interactions between NeuroticismxExtraversion (chi(2)=4.49, p=.03) and ExtraversionxConscientiousness (chi(2)=5.91, p=.01) were also associated with response. These results were mostly replicated across the treatment-completer and intent-to-treat samples. CONCLUSIONS: Dimensional personality traits predict response for individuals with MDD. LIMITATIONS: This study did not examine facet-level traits, patient pre-morbid personality and functioning, and additional patient characteristics. Results may not be generalizable to severely depressed or treatment refractory patients.
Authors: Alexander J Shackman; Do P M Tromp; Melissa D Stockbridge; Claire M Kaplan; Rachael M Tillman; Andrew S Fox Journal: Psychol Bull Date: 2016-10-10 Impact factor: 17.737
Authors: Marta Peciña; Hamdan Azhar; Tiffany M Love; Tingting Lu; Barbara L Fredrickson; Christian S Stohler; Jon-Kar Zubieta Journal: Neuropsychopharmacology Date: 2012-11-16 Impact factor: 7.853
Authors: Mieke Decuyper; Olivier F Colins; Barbara De Clercq; Robert Vermeiren; Eric Broekaert; Patricia Bijttebier; Annelore Roose; Filip De Fruyt Journal: Child Psychiatry Hum Dev Date: 2013-04
Authors: Amy M Cohn; Elizabeth E Epstein; Barbara S McCrady; Noelle Jensen; Dorian Hunter-Reel; Kelly E Green; Michelle L Drapkin Journal: J Stud Alcohol Drugs Date: 2011-01 Impact factor: 2.582